SEC Form 4 · accession 0001076542-17-000074
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Rosellini
Officer — CHIEF EXECUTIVE OFFICER · Director · 10% Owner
Period of report
Sep 5, 2017
Accepted (ET)
Sep 27, 2017 · 1:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 5, 2017 | J | 475,000 | — | D | 2,575,000 | D | |
| Common StockF1 | Sep 5, 2017 | G | 156,000 | — | D | 2,419,000 | D | |
| Common StockF2 | holding | — | — | — | 12,543,807 | I | Shares owned by Rosellini Scientific LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 5, 2017, William Rosellini sold 475,000 shares of Common Stock of the Company for $15,000 to one individual and gifted 156,000 shares of Common Stock to four individuals in private transactions, for a total of 631,000 shares, leaving 2,419,000 shares of Common Stock held by Mr. Rosellini, individually.
- F2Rosellini Scientific LLC ("RS") is wholly-owned by William Rosellini. Mr. Rosellini has the power to vote and dispose of shares held by RS.